Lambarene (1)

Maputo (1)

Nanoro (1)

Ouagadougou (1)

Tororo (1)

Acute Malaria (1)

Not yet recruiting (1)

phase 2 (1)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)

m5717 330 mg (1)

m5717 500 mg (1)

m5717 660 mg (1)

pyronaridine 360 mg (1)

pyronaridine 540 mg (1)

pyronaridine 720 mg (1)

pyronaridine- artesunate (pyramax) 540 mg/180 mg (1)

pyronaridine-artesunate (pyramax) 360 mg/120 mg (1)

pyronaridine-artesunate (pyramax) 720 mg/240 mg (1)

drug (1)

Industry (1)

Interventional (1)

acute malaria

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Jan 9, 2023